364. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug currently being administered with the support of private insurance in acute hospitals. [66175/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Marie Sherlock under the heading Medicinal Products.
26 questions match, newest first.
366. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug that was approved by HSE’s EMT for approval for each of the years 2019 to date in 2026. [66173/26]
370. Deputy Marie Sherlock asked the Minister for Health the name of each cancer specific drug that was submitted to the HSE’s EMT for approval for each of the years 2019 to date in 2026. [66169/26]
372. Deputy Marie Sherlock asked the Minister for Health the number of new cancer specific drugs approved for reimbursement by the HSE for each of the years 2019 to date in 2026. [66166/26]
375. Deputy Marie Sherlock asked the Minister for Health the names of cancer specific drugs being administered via a clinical trial in 2026. [66189/26]
377. Deputy Marie Sherlock asked the Minister for Health the number of cancer specific drugs being administered via a clinical trial for each of the years from 2019 to date in 2026. [66187/26]
380. Deputy Marie Sherlock asked the Minister for Health the name of each non cancer specific drug that is being administered with the support of private insurance in acute hospitals in 2026. [66184/26]
382. Deputy Marie Sherlock asked the Minister for Health the number of non cancer specific drugs being administered with the support of private insurance in acute hospitals for each of the years 2019 to date in 2026. [66181/26]
386. Deputy Marie Sherlock asked the Minister for Health the number of cancer specific drugs being administered with the support of private insurance in acute hospitals for each of the years 2019 to date in 2026. [66177/26]
929. Deputy Marie Sherlock asked the Minister for Health for an update on the reimbursement process for Skyclarys for persons living with Friedreich’s ataxia; and if she will make a statement on the matter. [45289/26]
243. Deputy Marie Sherlock asked the Minister for Health if there has been engagement by the corporate pharmaceutical unit in the HSE with the manufacturers of miglustat with regard to juvenile Batten disease; if such medication can be reimbursed for an individual with the life limiting condition on compassionate grounds; and if she will make a statement on the matter. [37963/26]
303. Deputy Marie Sherlock asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy; and if she will make a statement on the matter. [38289/26]
453. Deputy Marie Sherlock asked the Minister for Health if she has requested the NCPP to consider a full review of relugolix with estradiol and norethisterone acetate. [31687/26]
454. Deputy Marie Sherlock asked the Minister for Health the submitted price of ryeqo (relugolix with estradiol and norethisterone acetate) at the time of the rapid review by the NCPP in 2022. [31688/26]
455. Deputy Marie Sherlock asked the Minister for Health to list the grounds upon which the NCPP rejected a full HTA examination of Ryeqo. [31689/26]
129. Deputy Marie Sherlock asked the Minister for Health the steps her Department is taking to urgently regulate the administration of dermal fillers as committed to in the programme for Government; when such regulation or legislation will be introduced; if she and her Department will engage with stakeholders regarding the best way to protect the public; if her Department received research from the Health Research Bo…
997. Deputy Marie Sherlock asked the Minister for Health when the HSE will make a decision on the reimbursement of a medication (details supplied); and if she will make a statement on the matter. [22282/26]
280. Deputy Marie Sherlock asked the Minister for Health the reason that preservative-free cosopt eye drops have not been made available on the drugs payment scheme given that it is being prescribed to patients in Ireland; the reason that the licence for preservative-free cosopt drops was withdrawn by the Health Products Regulatory Authority; and if she will make a statement on the matter. [13130/26]
200. Deputy Marie Sherlock asked the Minister for Health the expenditure cost under the community drug scheme for continuous glucose monitoring (CGM) sensors with associated systems for each of the years 2023, 2024 and 2025; the number of patients availing of CGM sensors under the scheme for each year; the number of those patients with type 1 and type 2 diabetes; and if she will make a statement on the matter. [6792/…
1650. Deputy Marie Sherlock asked the Minister for Health the steps she will take to engage with the market authorisation holders of medications (details supplied) to submit pricing and reimbursement applications for these drug treatments to commence in patients over 18 years of age who are diagnosed with spinal muscular atrophy; and if she will make a statement on the matter. [57883/25]
1817. Deputy Marie Sherlock asked the Minister for Health if consideration has been given to including the shingles vaccine (Herpes Zoster Vaccine) in the national immunisation programme, specifically for those with immunocompromising conditions, as recommended by NIAC in February 2024; and if she will make a statement on the matter. [58694/25]
351. Deputy Marie Sherlock asked the Minister for Health the measures her Department is taking to stop novel nicotine products, such as nicotine pearls, from entering and being sold on the marketplace; and if she will make a statement on the matter. [55963/25]
352. Deputy Marie Sherlock asked the Minister for Health the powers she has to prevent novel nicotine products being sold on the market before they have been regulated as genuine tobacco cessation products; and if she will make a statement on the matter. [55964/25]
113. Deputy Marie Sherlock asked the Minister for Health the action she has taken to ensure that community pharmacists will administer the free hormone replacement therapy, HRT, scheme from 1 June 2025; and if she will make a statement on the matter. [24511/25]
2199. Deputy Marie Sherlock asked the Minister for Health if she intends on introducing the shingles vaccine for chronic lymphocytic leukaemia patients under the medical card or drug payment scheme; and if she will make a statement on the matter. [19692/25]